Please understand that cancer is big business. The cancer industry is spending virtually nothing of its multi-billion dollar resources on effective prevention strategies, such as dietary guidelines, exercise and obesity education. Instead, it pours its money into treating cancer, not preventing or curing it.
The typical cancer patient spends $50,000 fighting the disease. Chemotherapy drugs are among the most expensive of all treatments, many ranging from $3,000 to $7,000 for a one-month supply.
If the cancer industry allows a cure, then their patient base goes away. It makes more sense to keep a steady stream of cancer patients alive, but sick and coming back for more.(1)
One cure that the FDA seems to want to deny exists is Intravenous Vitamin C Therapy
Vitamin C has a broad spectrum antioxidant function with the ability to protect cell structures and DNA from free radical damage. Vitamin C is remarkably safe even in enormously high doses. Compared to commonly used prescription drugs, side effects are virtually nonexistent. No matter how high the concentration, vitamin C does not harm healthy cells. Yet, through an array of enzymatic and metabolic reactions, vitamin C has an impressive ability to protect and treat and wide range of diseases, including cancer. When something is this effective at treating disease, the FDA will stop at nothing to prevent public access.